Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irene Feroce

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)|March 2, 2016
A Randomized, Placebo-Controlled, Phase II, Presurgical Biomarker Trial of Celecoxib Versus Exemestane in Postmenopausal Breast Cancer PatientsValentina Aristarco, Davide Serrano, Sara Gandini, et al.
Cancers|May 14, 2025
Germline Testing in Breast Cancer: A Single-Center Analysis Comparing Strengths and Challenges of Different ApproachesMonica Marabelli, Mariarosaria Calvello, Elena Marino, et al.
Biomedicines|November 27, 2025
Characterization of a Genetic Variant in <i>BARD1</i> in Subjects Undergoing Germline Testing for Hereditary TumorsElena Marino, Elena Belloni, Matteo Dal Molin, et al.
Cancers|October 16, 2025
Impact of Epigenome-Wide Methylation and Breast Cancer Recurrence in Women Tested Negative for BRCA Genes: The Breast Methylation Risk (BREMERI) StudySilvia Polidoro, Harriet Johansson, Giovanni Cugliari, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 5, 2020
Is tumor testing efficiency for Lynch syndrome different in rectal and colon cancer?Monica Marabelli, Sara Gandini, Paola Raviele Rafaniello, et al.
Cancer Metastasis Reviews|October 22, 2014
E-cadherin germline mutation carriers: clinical management and genetic implicationsGiovanni Corso, Joana Figueiredo, Roberto Biffi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 14, 2011
Prognostic effect of circulating adiponectin in a randomized 2 x 2 trial of low-dose tamoxifen and fenretinide in premenopausal women at risk for breast cancerDebora Macis, Sara Gandini, Aliana Guerrieri-Gonzaga, et al.
JAMA Network Open|July 8, 2026
Germline Multigene Panel Testing in Women With Invasive Lobular CancerGiovanni Corso, Elena Marino, Francesca Fava, et al.
Genes|January 25, 2025
Hereditary Breast Cancer: Comprehensive Risk Assessment and Prevention StrategiesEliza Del Fiol Manna, Davide Serrano, Laura Cazzaniga, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 26, 2024
Fenretinide in Young Women at Genetic or Familial Risk of Breast Cancer: A Placebo-Controlled Biomarker TrialValentina Aristarco, Davide Serrano, Patrick Maisonneuve, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Cancer Prevention Research (Philadelphia, Pa.)|March 2, 2016
A Randomized, Placebo-Controlled, Phase II, Presurgical Biomarker Trial of Celecoxib Versus Exemestane in Postmenopausal Breast Cancer PatientsValentina Aristarco, Davide Serrano, Sara Gandini, et al.
Cancers|May 14, 2025
Germline Testing in Breast Cancer: A Single-Center Analysis Comparing Strengths and Challenges of Different ApproachesMonica Marabelli, Mariarosaria Calvello, Elena Marino, et al.
Biomedicines|November 27, 2025
Characterization of a Genetic Variant in <i>BARD1</i> in Subjects Undergoing Germline Testing for Hereditary TumorsElena Marino, Elena Belloni, Matteo Dal Molin, et al.
Cancers|October 16, 2025
Impact of Epigenome-Wide Methylation and Breast Cancer Recurrence in Women Tested Negative for BRCA Genes: The Breast Methylation Risk (BREMERI) StudySilvia Polidoro, Harriet Johansson, Giovanni Cugliari, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 5, 2020
Is tumor testing efficiency for Lynch syndrome different in rectal and colon cancer?Monica Marabelli, Sara Gandini, Paola Raviele Rafaniello, et al.
Cancer Metastasis Reviews|October 22, 2014
E-cadherin germline mutation carriers: clinical management and genetic implicationsGiovanni Corso, Joana Figueiredo, Roberto Biffi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 14, 2011
Prognostic effect of circulating adiponectin in a randomized 2 x 2 trial of low-dose tamoxifen and fenretinide in premenopausal women at risk for breast cancerDebora Macis, Sara Gandini, Aliana Guerrieri-Gonzaga, et al.
JAMA Network Open|July 8, 2026
Germline Multigene Panel Testing in Women With Invasive Lobular CancerGiovanni Corso, Elena Marino, Francesca Fava, et al.
Genes|January 25, 2025
Hereditary Breast Cancer: Comprehensive Risk Assessment and Prevention StrategiesEliza Del Fiol Manna, Davide Serrano, Laura Cazzaniga, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 26, 2024
Fenretinide in Young Women at Genetic or Familial Risk of Breast Cancer: A Placebo-Controlled Biomarker TrialValentina Aristarco, Davide Serrano, Patrick Maisonneuve, et al.
Pageof 4